Based on the above results, we clarified that the overexpression of ITGB3BP can lead to poor prognosis in glioma patients; however, the mechanism by which ITGB3BP participates in regulating the pathological progress of glioma needs to be further explained. This evidence concerns the gene ITGB3BP and central nervous system cancer.